复星医药复泽霖®利丙双卡因乳膏在阿里健康线上首发_老虎社区_美港股上老虎

复星医药复泽霖®利丙双卡因乳膏在阿里健康线上首发

阿里健康02-17

近日，复星医药旗下复星万邦销售的复泽霖®利丙双卡因乳膏在阿里健康首发。该产品是一种外用表面麻醉剂，适用于皮肤穿刺及浅层外科手术前的镇痛，已在全球范围内拥有长期应用历史。此次合作，标志着复星医药进一步拓展院外市场，携手阿里健康共同为消费者提供更便捷、专业、合规的镇痛解决方案。作为国家药品监督管理局批准用于皮肤穿刺及浅层外科手术镇痛的处方药，利丙双卡因乳膏自1998年在中国上市以来，一直是临床基础麻醉...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2612112664?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-17 22:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2612112664","market":"hk","top_or_hot":-1,"title":"复星医药复泽霖®利丙双卡因乳膏在阿里健康线上首发","media":"阿里健康","content":"<div>\n<p>近日，复星医药旗下复星万邦销售的复泽霖®利丙双卡因乳膏在阿里健康首发。该产品是一种外用表面麻醉剂，适用于皮肤穿刺及浅层外科手术前的镇痛，已在全球范围内拥有长期应用历史。此次合作，标志着复星医药进一步拓展院外市场，携手阿里健康共同为消费者提供更便捷、专业、合规的镇痛解决方案。作为国家药品监督管理局批准用于皮肤穿刺及浅层外科手术镇痛的处方药，利丙双卡因乳膏自1998年在中国上市以来，一直是临床基础麻醉...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217225235a7047955&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药复泽霖®利丙双卡因乳膏在阿里健康线上首发</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药复泽霖®利丙双卡因乳膏在阿里健康线上首发\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-17 22:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217225235a7047955&s=b><strong>阿里健康</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，复星医药旗下复星万邦销售的复泽霖®利丙双卡因乳膏在阿里健康首发。该产品是一种外用表面麻醉剂，适用于皮肤穿刺及浅层外科手术前的镇痛，已在全球范围内拥有长期应用历史。此次合作，标志着复星医药进一步拓展院外市场，携手阿里健康共同为消费者提供更便捷、专业、合规的镇痛解决方案。作为国家药品监督管理局批准用于皮肤穿刺及浅层外科手术镇痛的处方药，利丙双卡因乳膏自1998年在中国上市以来，一直是临床基础麻醉...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217225235a7047955&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1615","symbol_name":"港股-互联网","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217225235a7047955&s=b","article_id":"2612112664","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217225235a7047955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2612112664","pubTimestamp":1771339691,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，复星医药旗下复星万邦销售的复泽霖利丙双卡因乳膏在阿里健康首发。此次合作，标志着复星医药进一步拓展院外市场，携手阿里健康共同为消费者提供更便捷、专业、合规的镇痛解决方案。近年来，利丙双卡因乳膏在公立医院及消费医疗市场均呈现稳步增长。政策监管与学术共识的双重加持，为复泽霖利丙双卡因乳膏开辟出广阔的合规替代空间。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1615":"港股-互联网","02196":"复星医药","BK1502":"双十一","BK1189":"医疗保健技术","BK1584":"蚂蚁金服概念","BK1247":"药品零售","BK1617":"AI医疗","BK1142":"互联网与直销零售","BK1571":"互联网医疗","BK1501":"阿里概念股","BK1589":"北水核心资产","BK1191":"制药","BK1515":"抗疫概念","BK1610":"ETF&股票定投概念","BK1593":"医美概念股","BK1591":"就地过年概念","00241":"阿里健康"},"translate_title":"Fosun Pharma Fuzelin ® Liprodicaine cream debuts on Alibaba Health Online","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1.5,"02196":1.5},"content_text":"近日，复星医药旗下复星万邦销售的复泽霖®利丙双卡因乳膏在阿里健康首发。该产品是一种外用表面麻醉剂，适用于皮肤穿刺及浅层外科手术前的镇痛，已在全球范围内拥有长期应用历史。此次合作，标志着复星医药进一步拓展院外市场，携手阿里健康共同为消费者提供更便捷、专业、合规的镇痛解决方案。作为国家药品监督管理局批准用于皮肤穿刺及浅层外科手术镇痛的处方药，利丙双卡因乳膏自1998年在中国上市以来，一直是临床基础麻醉的重要选择。然而，随着医美、男科等消费医疗场景的蓬勃发展，该产品在院外市场的应用也迅速显性化，在男科领域，它被《早泄诊断与治疗指南》列为一线推荐方案；在蓬勃发展的轻医美市场，它则成为术前镇痛的合规首选。近年来，利丙双卡因乳膏在公立医院及消费医疗市场均呈现稳步增长。根据微信公众号邴药说的测算，利丙双卡因乳膏国内市场持续向上增长，2024年利丙双卡因乳膏在公立医疗机构终端销售额超过4.2亿元，加上医美和早泄场景的应用，利丙双卡因乳膏市场规模超过10亿元。2024年，国家药监局药品审评中心发布《利多卡因/丙胺卡因乳膏生物等效性研究技术指导原则》，同年11月，国内首部《皮肤表面麻醉制剂临床应用专家共识》正式刊发。同时，欧洲泌尿外科协会等国际权威指南也对此类复方乳膏给予推荐。政策监管与学术共识的双重加持，为复泽霖®利丙双卡因乳膏开辟出广阔的合规替代空间。伴随政策规范的逐步完善与用户需求的日益凸显，复星医药积极推动该产品走向更广阔的市场。此次选择与阿里健康合作，正是基于作为“新特药首发阵地”在数字化健康服务方面的平台优势，旨在更直接地触达注重隐私、便捷与安全的消费者。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}